S-1: Ispire Technology Inc. Announces Proposed Public Offering of Common Stock

Ispire Technology Inc. plans to offer up to 2,272,727 shares of common stock at an assumed price of $11.00 per share.

Summary

• Ispire Technology Inc. has filed a Form S-1 registration statement for a proposed public offering of up to 2,272,727 shares of its common stock.
• The assumed public offering price is $11.00 per share, based on the last reported sale price on the Nasdaq Capital Market on January 30, 2024.
• The company intends to use the net proceeds from this offering in connection with the establishment and operation of manufacturing facilities in California and Malaysia as well as working capital and general corporate purposes, including research and development.
• Roth Capital Partners, China Renaissance Securities (Hong Kong) Limited, TFI Securities and Futures Limited and Prime Number Capital, LLC are acting as placement agents for the offering.
• The company is an emerging growth company and a smaller reporting company, which allows for reduced public company reporting requirements.
• A joint venture with Berify is planned, with Ispire contributing up to $10 million for research and development and regulatory submissions.
• Preliminary estimates for the three and six months ended December 31, 2023, indicate revenue in the range of $40 million to $44 million and $83 million to $87 million, respectively, driven primarily by cannabis products.
• Gross profit for the same periods is expected to be in the range of $6 million to $7 million and $12 million to $14 million, respectively.
• Revenue from cannabis vaping products is expected to be in the range of $20 million to $22 million and $37 million to $39 million for the three and six month periods ended December 31, 2023, respectively.

Sentiment

Score: 6

Explanation: The document presents a mixed sentiment. While it highlights growth opportunities and expansion plans, it also acknowledges risks and uncertainties associated with the business and the offering itself.

Positives

• The company is expanding its manufacturing capabilities with new facilities in California and Malaysia.
• The company is entering into a joint venture with Berify to develop new technologies.
• The company is experiencing revenue growth, particularly in the cannabis vaping products segment.
• The company has a global distribution network of more than 150 distributors.
• The company holds several ISO certifications for its Malaysian facility, including ISO9001, ISO14001, ISO13485, and a GMP certification.

Negatives

• The actual public offering price may be at a discount to the current market price.
• There is no minimum number of shares required to be sold, which may reduce the proceeds received by the company.
• The preliminary financial estimates are subject to change and have not been audited.
• The company is a controlled company under Nasdaq listing rules, which means it is exempt from certain corporate governance requirements.
• The company relies on a related party, Shenzhen Yi Jia, for a majority of its manufacturing.

Risks

• The company may not use the net proceeds from the offering effectively.
• Investors will experience immediate and substantial dilution in the net tangible book value of the shares.
• The company may not raise the amount of capital it believes is required for its business plans.
• Future sales of a significant number of shares could depress the market price.
• The company does not anticipate paying any cash dividends in the foreseeable future.
• The company relies on one customer for a significant portion of its sales.
• The company is exposed to risks relating to its relationship with a related party, Shenzhen Yi Jia.
• The anticipated Joint Venture is subject to the execution of definitive documentation and not certain to be successful.
• The preliminary financial estimates represent managements current estimates and are subject to change.

Future Outlook

The company anticipates that the growing popularity of cannabis in the United States will coincide with an increasingly favorable political environment which they believe will increase the demand for their cannabis vaping products.

Industry Context

The market for cannabis/CBD vaping is expected to reach $20.5 billion in 2031 according to Transparency Market Research.

Related Party Transactions

• A majority of the company's products are manufactured and supplied by Shenzhen Yi Jia, which is 95% owned by the company's co-chief executive officer and controlling stockholder, Tuanfang Liu.

Stakeholder Impact

• The offering will dilute the ownership of existing shareholders.
• The company's expansion plans could create new jobs.
• The joint venture with Berify could lead to new and improved products for customers.

Next Steps

• The company expects to receive its first fully automated assembly system and related equipment in its California facility in the first quarter of 2024 and expects commercial scale operation to begin there in the first half of 2024.
• The company expects its manufacturing facility in Malaysia will commence commercial scale operation in the first half of 2024.
• The Parties are required to negotiate in good faith to execute the Definitive Documents in accordance with the terms contained in the Term Sheet.
• The company will file with the Commission pursuant to Rules 430A and 424(b) under the Securities Act, and the rules and regulations (the Rules and Regulations) of the Commission promulgated thereunder, a final prospectus relating to the placement of the Shares and will advise the Placement Agents of all further information (financial and other) with respect to the Company required to be set forth therein.

Key Dates

Keywords

public offering, common stock, cannabis vaping, Ispire Technology, manufacturing facilities, financial results, emerging growth company, placement agents, Berify, joint venture, revenue, gross profit, dilution, risk factors, securities